You require stable and pure AAV vectors to ensure your gene therapy product is safe and effective.
To develop effective vectors, you need to assess a number of their Critical Quality Attributes (CQAs). Technologies like static light scattering (SLS) and dynamic light scattering (DLS) give you lots of insight into your viral vector CQAs, including their size, purity, tendency to aggregate, and even how much genetic material they contain.
Check out this infographic to learn what SLS and DLS tell you about your vector samples, and how this info helps you develop better gene therapy products.
